Blue Star Q2FY27 Revenue Up 21% to ₹2,931 Cr; Net Profit Jumps 25.4%
Blue Star's Q2FY27 consolidated revenue grew 21% to ₹2,930.95 crores. Operating profit increased 10.5% to ₹202.58 crores. Net profit jumped 25.4% to ₹123.91 crores, including an exceptional gain from the MedTech business sale. The order book stood at ₹7,229.22 crores. The company ended with a net cash position of ₹289.43 crores.
The substantial growth in revenue and net profit, coupled with the positive outlook and improved cash position, will likely have a significant positive impact on investor sentiment and the company's stock performance.
The company reported significant year-on-year growth in revenue and net profit, along with an improvement in its cash position, indicating a strong financial performance.
Blue Star Limited announced its financial results for the second quarter of FY27, ending September 30, 2026. The company's consolidated revenue from operations grew by 21.0% to ₹2,930.95 crores, compared to ₹2,422.37 crores in the same period of the previous year. Operating profit (EBITDA excluding other income) increased by 10.5% to ₹202.58 crores (6.9% of revenue), up from ₹183.41 crores (7.6% of revenue) in Q2FY26.
Net profit for Q2FY27 saw a significant rise of 25.4%, reaching ₹123.91 crores from ₹98.78 crores in the prior year's corresponding quarter. This growth was bolstered by an exceptional gain of ₹23.02 crores recognized on the sale of the MedTech business during the quarter. Earnings per share (EPS) for Q2FY27 stood at ₹6.03, an increase from ₹4.80 in Q2FY26.
The carried forward order book as of September 30, 2026, marginally increased to ₹7,229.22 crores from ₹7,120.44 crores a year earlier. The company ended the quarter with a net cash position of ₹289.43 crores, a substantial improvement from net borrowings of ₹417.06 crores as of September 30, 2025.
Segment-wise, the Electro-Mechanical Projects, Commercial Air Conditioning Systems, Service, and International Business segment revenue grew by 16.3% to ₹1,935.99 crores. The Unitary Products Segment, including Room Air Conditioners and Commercial Refrigeration, recorded a revenue growth of 29.4% to ₹897.66 crores. The Professional Electronics and Industrial Systems Segment saw revenue increase by 51.2% to ₹97.30 crores, partly due to the sale of the MedTech business on August 31, 2026.
For the half-year ended September 30, 2026 (H1FY27), revenue from operations was ₹6,308.87 crores, a 16.7% increase over the previous year. Net profit for the half-year was ₹226.42 crores, compared to ₹219.60 crores in H1FY26, which included exceptional gains of ₹32.19 crores.
Vir S Advani, Chairman & Managing Director, expressed confidence in sustaining revenue growth momentum in H2FY27, focusing on strengthening profitability through calibrated price revisions, product cost optimization, and improved operational efficiencies.
What to do with a filing like this
Blue Star Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Blue Star Limited. Read the original for the full detail.